[HTML][HTML] Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets

Y Xia, D Gao, X Wang, B Liu, X Shan, Y Sun… - Frontiers in …, 2024 - frontiersin.org
In the genesis and progression of cardiovascular diseases involving both innate and
adaptive immune responses, inflammation plays a pivotal and dual role. Studies in …

[HTML][HTML] Evolving Strategies for Use of Phytochemicals in Prevention and Long-Term Management of Cardiovascular Diseases (CVD)

DD Haines, FM Cowan, A Tosaki - International Journal of Molecular …, 2024 - mdpi.com
This report describes major pathomechanisms of disease in which the dysregulation of host
inflammatory processes is a major factor, with cardiovascular disease (CVD) as a primary …

[HTML][HTML] Familial dilated cardiomyopathy: a novel MED9 short isoform identification

M Franzese, M Zanfardino, A Soricelli… - International Journal of …, 2024 - mdpi.com
Familial dilated cardiomyopathy (DCM) is among the leading indications for heart
transplantation. DCM alters the transcriptomic profile. The alteration or activation/silencing of …

[HTML][HTML] PBX/Knotted 1 homeobox-2 (PKNOX2) is a novel regulator of myocardial fibrosis

L Chen, H Li, X Liu, N Zhang, K Wang, A Shi… - … and Targeted Therapy, 2024 - nature.com
Much effort has been made to uncover the cellular heterogeneities of human hearts by
single-nucleus RNA sequencing. However, the cardiac transcriptional regulation networks …

[HTML][HTML] Ginsenoside RH4 inhibits Ang II-induced myocardial remodeling by interfering with NFIL3

Y Wang, X An, F Wang, Y Jiang - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Ventricular remodeling refers to the structural and functional changes of the heart under
various stimuli or disease influences and may also be accompanied by myocardial fibrosis …

The Role of Magnetic Resonance Imaging in Cardiomyopathies in the Light of New Guidelines: A Focus on Tissue Mapping

C Forleo, MC Carella, P Basile, D Mandunzio… - Journal of Clinical …, 2024 - mdpi.com
Cardiomyopathies (CMPs) are a group of myocardial disorders that are characterized by
structural and functional abnormalities of the heart muscle. These abnormalities occur in the …

[HTML][HTML] Variants in structural cardiac genes in patients with cancer therapy-related cardiac dysfunction after anthracycline chemotherapy: a case control study

HM Boen, M Alaerts, I Goovaerts, JB Saenen… - Cardio-Oncology, 2024 - Springer
Background Variants in cardiomyopathy genes have been identified in patients with cancer
therapy-related cardiac dysfunction (CTRCD), suggesting a genetic predisposition for the …

[HTML][HTML] Sudden Cardiac Death, Post-Mortem Investigation: A Proposing Panel of First Line and Second Line Genetic Tests

F Del Duca, A Ghamlouch, AC Manetti… - Journal of Personalized …, 2024 - mdpi.com
Investigating the causes of Sudden cardiac death (SCD) is always difficult; in fact, genetic
cardiac conditions associated with SCD could be “silent” even during autopsy investigation …

Efficacy and Safety of Kuoxin Formula in the Treatment of Dilated Cardiomyopathy-Related Heart Failure: Study Protocol of a Randomized, Double-Blind, Placebo …

Q Wu, S An, RJ Lee, D Gao, Y Zhou… - … Journal of General …, 2024 - Taylor & Francis
Background Dilated cardiomyopathy (DCM) is a severe heterogeneous cardiomyopathy
characterized by cardiac enlargement and declining heart function, often leading to …

[HTML][HTML] Comprehensive review on gene mutations contributing to dilated cardiomyopathy

S Wang, Z Zhang, J He, J Liu, X Guo… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Dilated cardiomyopathy (DCM) is one of the most common primary myocardial diseases.
However, to this day, it remains an enigmatic cardiovascular disease (CVD) characterized …